The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary analysis of FOLFIRI regimen with or without bevacizumab as second-line systemic therapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma.
 
Xiaoying Zhao
No Relationships to Disclose
 
Chen Chen Wang
No Relationships to Disclose
 
Wen Zhang
No Relationships to Disclose
 
Xiaodong Zhu
No Relationships to Disclose
 
Weijian Guo
No Relationships to Disclose
 
Zhi-Yu Chen
No Relationships to Disclose